Start Date
August 31, 2018
Primary Completion Date
December 30, 2019
Study Completion Date
February 9, 2022
Gemcitabine
Gemcitabine is a type of chemotherapy medication used to interfere with the cancer cells' ability to grow and divide.
Nab-paclitaxel
NAB-paclitaxel is a type of chemotherapy called a microtubule inhibitor. Microtubule inhibitors interfere with a cancer cell's ability to grow and divide.
Aldoxorubicin HCl
Albumin-binding prodrug of doxorubicin HCl
ALT-803
Recombinant human super agonist interleukin-15 (IL-15) complex
ETBX-011
Ad5 \[E1-, E2b-\]-CEA
ETBX-021
Ad5 \[E1-, E2b-\]-human epidermal growth factor receptor 2 \[HER2\] vaccine
ETBX-051
Ad5 \[E1-, E2b-\]-Brachyury vaccine
ETBX-061
Ad5 \[E1-, E2b-\]-mucin 1\[MUC1\]
GI-4000
Vaccine derived from recombinant Saccharomyces cerevisiae yeast expressing mutant Ras proteins
GI-6207
CEA yeast vaccine
GI-6301
Brachyury yeast vaccine
haNK
NK-92 \[CD16.158V, ER IL-2\]
Avelumab
Avelumab
Bevacizumab
Bevacizumab
Capecitabine
Capecitabine
Cyclophosphamide
2-\[bis(2-chloroethyl)amino\]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate
5-Fluorouracil
5-fluoro-2,4 (1H,3H)-pyrimidinedione
Leucovorin
L-Glutamic acid, N-\[4-\[\[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl\]amino\]benzoyl\]-, calcium salt
Oxaliplatin
Oxaliplatin
Chan Soon-Shiong Institute for Medicine, El Segundo
Lead Sponsor
ImmunityBio, Inc.
INDUSTRY